BIOMAT Database Logo BIOMAT Database Logo

Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitors. 2010

Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. unmesh.shah@spcorp.com

Inhibition of 11beta-HSD1 has demonstrated potential in the treatment of various components of metabolic syndrome. We wish to report herein the discovery of novel azabicyclic sulfonamide based 11beta-HSD1 inhibitors. Highly potent compounds exhibiting inhibitory activities at both human and mouse 11beta-HSD1 were identified. Several compounds demonstrated significant in vivo activity in the mouse cortisone challenge assay.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D003348 Cortisone A naturally occurring glucocorticoid that has been used in replacement therapy for ADRENAL INSUFFICIENCY and as an anti-inflammatory agent. Cortisone itself is inactive; it is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726) 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate,Adreson,Cortisone Acetate,Cortone Acetate
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D043205 11-beta-Hydroxysteroid Dehydrogenase Type 1 A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tissue; OVARY; and the CENTRAL NERVOUS SYSTEM. The enzyme acts reversibly and can use either NAD or NADP as cofactors. 11 beta-Hydroxysteroid Dehydrogenase Type 1,11beta-HSD1,11beta-HSD1 Reductase,11beta-Hydroxysteroid Dehydrogenase Type 1,11beta HSD1 Reductase,11beta Hydroxysteroid Dehydrogenase Type 1
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053961 Azabicyclo Compounds Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS. Azabicyclo(1.1.0)Butanes,Azabicyclo(2.2.2)Octanes,Azabicyclo(3.3.1)Nonanes,Azabicyclo(4.3.0)Nonanes,Azabicyclo(5.2.2)Undecanes

Related Publications

Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors.
August 2009, Bioorganic & medicinal chemistry letters,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
July 2010, ChemMedChem,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors.
November 2007, Bioorganic & medicinal chemistry letters,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
A highly efficient synthesis of potent and selective butyrolactam inhibitors of 11beta-HSD1.
August 2006, Organic letters,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
Discovery of orally active butyrolactam 11beta-HSD1 inhibitors.
November 2006, Bioorganic & medicinal chemistry letters,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
Discovery of potent and selective inhibitors of 11beta-HSD1 for the treatment of metabolic syndrome.
December 2006, Bioorganic & medicinal chemistry letters,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
April 2008, Bioorganic & medicinal chemistry letters,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
Recent advances in the discovery of 11beta-HSD1 inhibitors.
July 2008, Current opinion in drug discovery & development,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.
May 2007, Bioorganic & medicinal chemistry letters,
Unmesh Shah, and Craig D Boyle, and Samuel Chackalamannil, and Hana Baker, and Timothy Kowalski, and Julie Lee, and Giuseppe Terracina, and Lili Zhang
The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.
May 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!